Gordon Kevin K
- SEC CIK
- 0001218483
In the past year, 2 open-market sale filings worth $449.3K and no purchases.
Current role at each company
- PGNY Progyny, Inc.Directoras of Sep 18, 2026
- VCYT Veracyte, Inc.Directoras of Jun 10, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $449.3K
- 2 filings
- Net
- −$449.3K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Gordon Kevin K as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
PGNY Progyny, Inc.
Director5 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 26, 2023 (view filing) | May 24 | 2 days | Gordon Kevin KDirector | SSale | −1.41K | $38.24 | −$53.9K | −10.2%12.4K after | |
| Dec 13, 2023 (view filing) | Dec 11 | 2 days | Gordon Kevin KDirector | SSale | −2.50K | $35.93 | −$89.8K | −20.2%9.85K after | |
| Aug 13, 2025 (view filing) | Aug 11 | 2 days | Gordon Kevin KDirector | SSale | −2.50K | $22.04 | −$55.1K | −16.7%12.5K after | |
| May 29, 2026 (view filing) | May 27 | 2 days | Gordon Kevin KDirector | SSale | −5.50K | $24.99 | −$137.4K | −37.1%9.32K after | |
| Sep 18, 2026 (view filing)6:46 PM ET | Sep 10 | 8 days | Gordon Kevin KDirector | SSale | −11.5K | $27.12 | −$311.9K | −62.9%6.79K after | Amended |
VCYT Veracyte, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 10, 2022 (view filing) | Jun 8 | 2 days | Gordon Kevin KDirector | SSale | −15.0K | $18.50 | −$277.5K | −63.2%8.72K after |